{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:22:46Z","timestamp":1649092966760},"reference-count":18,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<p><bold>Objective.<\/bold> To identify factors affecting compliance with follow-up during treatment in confirmed malaria patients at two health centers in Haiti.<\/p>\n<p><bold>Methods.<\/bold> A prospective observational study of malaria patients undergoing treatment over a six-week period. Patients\u2019 return visits (follow-up visits) to the health centers for consultation in accordance with the physicians\u2019 requests were recorded and used to determine compliance. Socioeconomic data were obtained from patient enrollment questionnaires and through post-treatment interviews. The management practices and procedures at the health centers to retain patients were also reviewed. Descriptive statistics and Spearman\u2019s rank correlation were used to identify significant factors, which were used as variables in a logistic regression model.<\/p>\n<p><bold>Results.<\/bold> Sixty-eight percent of the malaria patients completed follow-up, with higher compliance being recorded in the larger, more established health center of Leogane (67%) than Cite Soleil (33%). The patient socioeconomic profiles differed between the two health center locations by level of education, religious diversity, household size, and percentage of married individuals. Crude logistic regression analyses identified health center location (OR = 0.179 [95% CI 0.064, 0.504]) and household size (OR = 1.374 [95% CI 1.056, 1.787]) to be associated with compliance. The adjusted model only identified health center location (OR = 0.226 [95% CI 0.056, 0.918]) as significantly associated with compliance.<\/p>\n<p><bold>Conclusion.<\/bold> Although patients\u2019 household size may be important according to the crude logistic regression analysis, in the adjusted analysis the site location of the health center where patients receive treatment was identified as the only important factor associated with follow-up compliance in malaria patients during treatment in Haiti. This information might be helpful to improve treatment outcomes and contribute to the monitoring of antimalarial resistance in Haiti.<\/p>","DOI":"10.26633\/rpsp.2021.150","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:27:19Z","timestamp":1639142839000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Investigations of socioeconomic factors associated with follow-up compliance with malaria treatment in Haiti"],"prefix":"10.26633","volume":"45","author":[{"given":"Tamar E.","family":"Carter","sequence":"first","affiliation":[{"name":"Baylor University, Waco, Texas, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Existe","sequence":"first","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 Publique et de la Population, Port-au-Prince, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madsen","family":"Beau de Rochars","sequence":"first","affiliation":[{"name":"University of Florida, Gainesville, Florida, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Okech","sequence":"first","affiliation":[{"name":"Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America"},{"name":"bernard.okech@usuhs.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11167","reference":[{"key":"ref1","unstructured":"World Health Organization. World malaria report 2019. Geneva: WHO; 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565721"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Rogier E, Herman C, Huber CS, Hamre KES, Pierre B, Mace KE, et al. Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016\u20132017. Emerg Infect Dis. 2020 May;26(5):902\u20139.","DOI":"10.3201\/eid2605.190556"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Morton LC, Huber C, Okoth SA, Griffing S, Lucchi N, Ljolje D, et al. Plasmodium falciparum Drug-Resistant Haplotypes and Population Structure in Postearthquake Haiti, 2010. Am J Trop Med Hyg. 2016 Oct 5;95(4):811\u20136.","DOI":"10.4269\/ajtmh.16-0214"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Neuberger A, Zhong K, Kain KC, Schwartz E. Lack of Evidence for Chloroquine-Resistant Plasmodium falciparum Malaria, Leogane, Haiti. Emerg Infect Dis. 2012 Sep;18(9):1487\u20139.","DOI":"10.3201\/eid1809.120605"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Boncy PJ, Adrien P, Lemoine JF, Existe A, Henry PJ, Raccurt C, et al. Malaria elimination in Haiti by the year 2020: an achievable goal? Malar J. 2015 Jun 5;14(1):237.","DOI":"10.1186\/s12936-015-0753-9"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Menard D, Dondorp A. Antimalarial Drug Resistance: A Threat to Malaria Elimination. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7).","DOI":"10.1101\/cshperspect.a025619"},{"key":"ref7","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: WHO; 2015. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/162441"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 2008 Mar 1;24(3):127\u201334.","DOI":"10.1016\/j.pt.2007.11.008"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Watkins WM, Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg. 1993 Feb;87(1):75\u20138.","DOI":"10.1016\/0035-9203(93)90431-O"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Yeung S, White NJ. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health TM IH. 2005 Feb;10(2):121\u201338.","DOI":"10.1111\/j.1365-3156.2004.01364.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Winnick S, Lucas DO, Hartman AL, Toll D. How do you improve compliance? Pediatrics. 2005 Jun;115(6):e718\u201324.","DOI":"10.1542\/peds.2004-1133"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005 Aug 4;353(5):487\u201397.","DOI":"10.1056\/NEJMra050100"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Jaiteh F, Dierickx S, Gryseels C, O\u2019Neill S, D\u2019Alessandro U, Scott S, et al. \u2018Some anti-malarials are too strong for your body, they will harm you.\u2019 Socio-cultural factors influencing pregnant women\u2019s adherence to anti-malarial treatment in rural Gambia. Malar J [Internet]. 2016 Apr 11 [cited 2020 Oct 21];15:195. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4827243\/.","DOI":"10.1186\/s12936-016-1255-0"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Liptak GS. Enhancing Patient Compliance in Pediatrics. Pediatr Rev. 1996 Apr 1;17(4):128\u201334.","DOI":"10.1542\/pir.17-4-128"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bruxvoort K, Goodman C, Kachur SP, Schellenberg D. How Patients Take Malaria Treatment: A Systematic Review of the Literature on Adherence to Antimalarial Drugs. PLoS One [Internet]. 2014 Jan 20 [cited 2020 Oct 21];9(1): e84555. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3896377\/.","DOI":"10.1371\/journal.pone.0084555"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Okech BA, Existe A, Romain JR, Memnon G, Victor YS, de Rochars MB, et al. Therapeutic Efficacy of Chloroquine for the Treatment of Uncomplicated Plasmodium falciparum in Haiti after Many Decades of its Use. Am J Trop Med Hyg. 2015 Mar 4;92(3):541\u20135.","DOI":"10.4269\/ajtmh.14-0302"},{"key":"ref17","unstructured":"Google Maps [Internet]. Google Maps. https:\/\/www.google.com\/maps\/."},{"key":"ref18","unstructured":"United States Agency for International Development [Internet]. Washington, DC: USAID; c2021 [cited 2021 Oct 21]. IDEA: Haiti, Education, Country Dashboard. Available from: https:\/\/idea.usaid.gov\/cd\/haiti\/education#tab-secondary-education"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/55295\/v45e1502021.pdf?sequence=1&isAllowed=y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:27:45Z","timestamp":1639142865000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/55295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":18,"alternative-id":["RPSP.2021.150"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2021.150","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]}}}